iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.900
-0.030 (-1.55%)
May 29, 2026, 4:00 PM EDT - Market closed
iBio, Inc. Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -27.61 | -18.38 | -24.91 | -65.01 | -50.3 | -23.21 |
Depreciation & Amortization | 1.07 | 1.13 | 1.25 | 1.38 | 3.49 | 2.41 |
Stock-Based Compensation | 1.22 | 1.53 | 2.04 | 4.39 | 4.38 | 1.59 |
Other Adjustments | 3.55 | -0.06 | 6.23 | 22.94 | 6.51 | 0.3 |
Change in Receivables | -0.07 | - | - | 6.1 | -0.89 | -10.63 |
Changes in Inventories | - | - | - | -1.02 | -3.87 | 0.77 |
Changes in Accounts Payable | 1.56 | 1.83 | -1.49 | -0.63 | 1.24 | 0.05 |
Changes in Accrued Expenses | 0.24 | -0.76 | -1.73 | 0.67 | 1.44 | 1.9 |
Changes in Unearned Revenue | -0.2 | 0.25 | 0.2 | -0.1 | 0.01 | -1.39 |
Changes in Other Operating Activities | -2.67 | -0.84 | -0.15 | -0.04 | 0.21 | -1.86 |
Operating Cash Flow | -21.61 | -15.3 | -18.55 | -30.44 | -37.48 | -30.06 |
Capital Expenditures | -0.56 | -0.02 | - | -5.74 | -7.33 | -4.92 |
Sale of Property, Plant & Equipment | - | - | 0.12 | 2.6 | - | - |
Purchases of Intangible Assets | - | - | - | - | -4.3 | -0.24 |
Proceeds from Sale of Intangible Assets | - | - | -0.21 | - | - | - |
Purchases of Investments | -32.43 | - | - | - | -7.12 | -23.82 |
Proceeds from Sale of Investments | - | - | - | 10.84 | 13.62 | 4 |
Payments for Business Acquisitions | - | - | - | -0.69 | - | - |
Other Investing Activities | 0.05 | 0.76 | 1 | - | - | -1.5 |
Investing Cash Flow | -27.54 | 0.74 | 0.91 | 7.01 | -5.13 | -26.48 |
Long-Term Debt Issued | - | - | 0.9 | 0.5 | - | - |
Long-Term Debt Repaid | 0.83 | 0.4 | 1.6 | 9.42 | - | - |
Net Long-Term Debt Issued (Repaid) | 0.83 | 0.4 | 2.5 | 9.92 | - | - |
Issuance of Common Stock | 90.61 | 9.92 | 25.73 | 11.49 | 0.08 | 78.33 |
Repurchase of Common Stock | - | - | 0.01 | 0.04 | 0.05 | - |
Net Common Stock Issued (Repurchased) | 90.61 | 9.92 | 25.73 | 11.53 | 0.13 | 78.33 |
Other Financing Activities | -6.03 | -0.59 | -0.52 | -0.23 | -6.15 | 0.51 |
Financing Cash Flow | 91.82 | 8.93 | 24.49 | 2.3 | -6.13 | 78.84 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - | 0.03 | - | -0 |
Net Cash Flow | 42.68 | -5.63 | 6.85 | -21.09 | -48.73 | 22.29 |
Free Cash Flow | -22.17 | -15.32 | -18.55 | -36.17 | -44.81 | -34.98 |
FCF Margin | -7388.33% | -3830.00% | -8246.22% | - | -2378.45% | -1475.50% |
Free Cash Flow Per Share | -0.31 | -1.46 | -4.84 | -59.11 | -102.76 | -89.42 |
Levered Free Cash Flow | -4.9 | -16.39 | -24.33 | -60.56 | -55.2 | -26.5 |
Unlevered Free Cash Flow | -29.52 | -17.01 | -18.55 | -34.81 | -34.51 | -34.15 |